Hypothesis proved...citric acid (citrate) does improve cancer: A case of a patient suffering from medullary thyroid cancer

Medical Hypotheses

Volumn 73, Issue 2, 2009, Pages 271-

  Halabe Bucay, Alberto ^a  

^a HOSPITAL ÁNGELES LOMAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; CALCITONIN; CALCITRIOL; CALCIUM CARBONATE; CITRIC ACID; OMEPRAZOLE; POTASSIUM; SUCRALFATE; THYROID HORMONE;

BEDTIME DOSAGE; CALCITONIN BLOOD LEVEL; CANCER PATIENT; CASE REPORT; CHILD; DRUG DOSE INCREASE; DRUG SAFETY; GENERAL CONDITION IMPROVEMENT; GLYCOLYSIS; HUMAN; HYPOTHESIS; LETTER; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHOOL CHILD; THERAPY EFFECT; THROAT SURGERY; THYROID MEDULLARY CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE;

CARCINOMA, MEDULLARY; CHILD; CITRIC ACID; HUMANS; MALE; THYROID NEOPLASMS;

EID: 67349102008     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.03.018     Document Type: Letter

References (2)

1. Halabe Bucay A. The biological significance of cancer: Mitochondria as a cause of cancer and the inhibition of glycolysis with citrate as a cancer treatment. Med Hypotheses 69 4 (2007) 826-828
2. Barbet J., Campion L., Kraeber-Bordéré F., and Chatal J.F. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90 11 (2005) 6077-6084